Chan Yue Li
Director/Board Member bei TAIWAN LIPOSOME COMPANY, LTD.
Profil
Chan Yue Li currently works at Taiwan Liposome Co., Ltd., as Director from 2014, Steminent Biotherapeutics, Inc., as Director from 2021, and Lin BioScience, Inc., as Director from 2016.
Mr. Li also formerly worked at UBI Pharma Inc., as Director.
Mr. Li received his graduate degree from the University of Iowa.
Aktive Positionen von Chan Yue Li
| Unternehmen | Position | Beginn |
|---|---|---|
| TAIWAN LIPOSOME COMPANY, LTD. | Director/Board Member | 18.06.2014 |
| LIN BIOSCIENCE, INC. | Director/Board Member | 13.10.2016 |
| STEMINENT BIOTHERAPEUTICS, INC | Director/Board Member | 08.12.2021 |
Ehemalige bekannte Positionen von Chan Yue Li
| Unternehmen | Position | Ende |
|---|---|---|
| UBI PHARMA INC. | Director/Board Member | - |
Ausbildung von Chan Yue Li
| University of Iowa | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| STEMINENT BIOTHERAPEUTICS, INC | Health Technology |
| UBI PHARMA INC. | Health Technology |
| LIN BIOSCIENCE, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Taiwan Liposome Co., Ltd.
 Taiwan Liposome Co., Ltd. Pharmaceuticals: MajorHealth Technology Taiwan Liposome Co., Ltd. engages in the research and development of lipid-based formulation drugs. Its products are used for pain management, eye disease treatment, and cancer treatment. The company was founded by Kee Lung Hong on November 10, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
